| Theragenics Corp. Q1 2010 Earnings Call Transcript Theragenics Corp. (TGX)Q1 2010 Earnings Call May 5, 2010 11:00 am ETComplete Story » seekingalpha.com |
Biogen Names Scangos as CEO Biogen Idec named George Scangos as chief executive, hiring him away from the same role at smaller drug developer Exelixis. online.wsj.com |
New Nutritionist: Your Grocer A number of grocery retailers are now pushing nutritional advice. Efforts include posting nutritional ratings on bin labels and hiring dietitians to advise shoppers on how to select healthier food. online.wsj.com |
The Upcoming Verdict on Arena's Obesity Drug Prohost Biotech submits:This Thursday an FDA advisory panel will discuss Arena’s (ARNA) drug Lorqess (lorcaserin) for obesity. The stock has already been cremated, losing more than 30% of its value because the Food and Drug Administration posted what insinuates that, on the one hand, clinical studies of lorcaserin showed the product did not meet the standard FDA guidance for industry developing products for weight management, i.e., that the difference in mean weight loss between the active-product and placebo-treated groups must be at least 5% for a statistically significant difference between the drug to be reviewed and the placebo. In this study, the average weight loss with lorcaserin was about 3% greater than the average weight loss for patients given a placebo. On the other hand, the FDA said a product is considered effective if it meets at least one of the criteria after one year of treatment, which Arena’s drug might have met. The agency said that about 23% of patients in the placebo group lost 5% or more of their body weight after one year compared to 47% of people being given lorcaserin twice a day. The results were 40% of people who took the drug once daily. This statement did not reach the eyes or ears of investors who were affected by fear more than by encouragement. Complete Story » seekingalpha.com |
Cord Blood America Remembers World's First Life Saved by Umbilical Cord Blood Stem Cells [PR Newswire] - In celebration of International Stem Cell Awareness Day, Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, has produced an interview with Natalie Curry, whose life was saved by umbilical cord blood stem cells, and her mother, Lea Ann Stiller, who played a key role in this medical breakthrough. us.rd.yahoo.com |